Nutraceutical News and Research RSS Feed - Nutraceutical News and Research

Nutraceutical, a portmanteau the words “nutrition” and “pharmaceutical”, is a food or food product that provides health and medical benefits, including the prevention and treatment of disease.
DSM Venturing invests in ZeaVision Holdings

DSM Venturing invests in ZeaVision Holdings

ZeaVision Holdings, Inc., maker of the EyePromise® brand of doctor-recommended nutraceuticals, has received an equity investment from DSM Venturing, the corporate venture arm of Royal DSM, the global life sciences and material sciences company. [More]
Fi Asia-China 2014 held in Shanghai proved to be a great success

Fi Asia-China 2014 held in Shanghai proved to be a great success

China's leading nutritional ingredients event, Food ingredients (Fi) Asia China, Health ingredients (Hi) and Natural ingredients (Ni), took place this June 26-28 in Shanghai, China and was a great success. [More]
Encapsula releases 2 new liposome based products

Encapsula releases 2 new liposome based products

Encapsula NanoSciences announces the release of two new liposome ­based products; Curcusome® and Taurosome™. Curcusome® or liposomal curcumin is a nutraceutical supplement that comes innovatively packaged in a powder ­release cap for consumer ease. [More]
GrowBLOX enters Florida Medical Marijuana Market through new subsidiary, GB Sciences

GrowBLOX enters Florida Medical Marijuana Market through new subsidiary, GB Sciences

GrowBLOX Sciences, Inc. a medical marijuana research and development company, is pleased to announce it has entered the Florida Medical Marijuana Market through its new subsidiary, GB Sciences Florida, LLC. With nearly 20 million residents, Florida is poised to be the biggest medical marijuana market outside of California. [More]
Kainos Capital announces acquisition of Unilever's Slim-Fast brand

Kainos Capital announces acquisition of Unilever's Slim-Fast brand

Kainos Capital, a firm specializing in acquiring and managing food and consumer brands, today announced that it has acquired the Slim-Fast brand from Unilever. Unilever will retain a minority stake in the business. Terms of the transaction were not disclosed. [More]
Ophthalmologist recommends alternative therapy for Graves' eye disease

Ophthalmologist recommends alternative therapy for Graves' eye disease

Don Parker was facing a second surgery to treat the bulging eyes and double vision he was experiencing due to Graves' eye disease. [More]

NTRR’s subsidiary Diamond Anvil Designs to release cutting-edge vaporizer pen next month

Neutra Corp., a provider of all-natural wellness solutions, announced today that its wholly owned subsidiary, Diamond Anvil Designs, is preparing to release its cutting-edge new vaporizer pen next month. [More]
Kush Creams to manufacture and distribute medical marijuana product, 5 Hour High

Kush Creams to manufacture and distribute medical marijuana product, 5 Hour High

Alternaturals, Inc., Symbol (OTCPink:ANAS) today announced that it has chosen Kush Creams, a Washington based, medical marijuana grower and distributor with award winning strains and products, to manufacture and distribute its long awaited medical marijuana product, 5 Hour High©. [More]
New book documents groundbreaking studies on modified citrus pectin

New book documents groundbreaking studies on modified citrus pectin

One of the nation's leading writers on the use of naturopathic medicine has released a new book documenting groundbreaking studies on modified citrus pectin (MCP) and its application for addressing serious health issues like cancer, heart disease, chronic inflammation and fibrosis. [More]

GrowBLOX Sciences’ patent-pending technology for medical-grade cannabis comes off production line

GrowBLOX Sciences, Inc. (OTCQB: GBLX) announced today that the first of its patent pending proprietary agricultural indoor growing system for medical-grade cannabis has come off the production line. [More]
GrowBLOX Sciences relocates corporate headquarters to Las Vegas, Nevada

GrowBLOX Sciences relocates corporate headquarters to Las Vegas, Nevada

GrowBLOX Sciences, Inc. a biotechnology and research company, announced today that The Company has relocated its corporate headquarters to Las Vegas, Nevada and has centralized its CFO and team in the heart of Clark County in anticipation of its Nevada project. [More]
Study identifies role of additive monosodium glutamate in obesity and liver disease

Study identifies role of additive monosodium glutamate in obesity and liver disease

The commonly used food additive monosodium glutamate (MSG) has been linked to obesity and disorders associated with the metabolic syndrome including progressive liver disease. [More]

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability. [More]

Neutra to unveil new vapor pen at Cannabis Cup trade show

The executive leadership from Neutra Corp. will travel to Denver this week to seek out distribution and build brand awareness for the company's new vapor pen at one of the world's largest cannabis conventions: the Cannabis Cup. [More]

Neutra seeks new breakthroughs in greenhouse cultivation to develop and market around globe

In the company's quest to introduce new technology on the cutting edge of the indoor horticulture industry, Neutra Corp. (OTCBB: NTRR) is seeking out new breakthroughs in greenhouse cultivation to develop and market around the globe. [More]
Otsuka inks agreement with Eisai to acquire rights to hematological cancer treatment Dacogen

Otsuka inks agreement with Eisai to acquire rights to hematological cancer treatment Dacogen

Otsuka Pharmaceutical Co., Ltd. has announced an agreement with Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. to acquire rights to the hematological cancer treatment Dacogen and to an enzyme inhibitor, E7727. [More]
Omega Protein's fourth quarter 2013 revenues increase 4% to $66 million

Omega Protein's fourth quarter 2013 revenues increase 4% to $66 million

Omega Protein Corporation, a nutritional product company and a leading integrated producer of omega-3 fish oil and specialty protein products, today reported financial results for the fourth quarter and full year ended December 31, 2013. [More]
Neutra acquires cutting-edge developer of smoke-free nutraceutical delivery systems

Neutra acquires cutting-edge developer of smoke-free nutraceutical delivery systems

Neutra Corp. (OTCBB: NTRR), a fast-growing provider of all-natural wellness solutions, announced today that it acquired Diamond Anvil Designs (DA), a cutting-edge developer of smoke-free nutraceutical delivery systems. [More]
Scientist receives grant to study biochemical fate of nanoemulsion-based food delivery systems in GI tract

Scientist receives grant to study biochemical fate of nanoemulsion-based food delivery systems in GI tract

​Food scientist Hang Xiao of the University of Massachusetts Amherst recently received a four-year, $491,220 grant to study the biochemical fate of nanoemulsion-based food delivery systems in the gastrointestinal (GI) tract, hoping to re-shape them and enhance the absorption of beneficial food components encapsulated in delivery systems. [More]
EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

Otsuka Pharmaceutical Co., Ltd. announced today that the European Medicines Agency (EMA) has accepted the submission of a marketing authorisation application (MAA) for the potential approval of tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD). [More]